Hello and Welcome to Patientsville.com, Your Source for all UMATROPE information. We are dedicated to provide You with UMATROPE safety information. Learn about UMATROPE serious adverse events reported to Food and Drug Administration (FDA).
Medications A-Z: A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
UMATROPE Safety Reports
Total UMATROPE reports: 2.UMATROPE FDA safety alerts: No.
Reported hospitalizations: 2.
Take UMATROPE Side Effects Survey or Share Your UMATROPE Story. Read More Here.
Physician from FRANCE reported UMATROPE problem on June 26, 2006. Female patient, child 9 years of age, was diagnosed with growth retardation and was treated with UMATROPE. After drug was administered, patient experienced the following problems/side effects: brain oedema, headache, intracranial pressure increased, papilloedema. UMATROPE dosage: unknown. Patient was hospitalized. Patient recovered.
UMATROPE problem was reported by a Physician from FRANCE on Aug 13, 2007. Male patient, 15 years of age, weighting 149.5 lb, was diagnosed with growth hormone deficiency, hypothyroidism and was treated with UMATROPE. After drug was administered, patient experienced the following problems/side effects: scrotal oedema. UMATROPE dosage: 1.7 MG, DAILY (1/D). During the same period patient was treated with LEVOTHYROXINE. Patient was hospitalized. Patient recovered.